Home » Rapid Micro Biosystems Releases Service Pack 2 Software for Growth Direct
Rapid Micro Biosystems Releases Service Pack 2 Software for Growth Direct
Rapid Micro Biosystems, a company developing innovative products for faster and automated detection of microbial contamination, today announced the availability of Service Pack 2 software for the Growth Direct System. The new release includes both user and industry driven product features that enable Quality Control labs to improve their performance by optimizing workflow and eliminating waste. These capabilities will drive the transformation from manual quality control to an automated, paperless laboratory.
Increased Manufacturing Efficiency and Throughput
New alerting features let the business respond faster to key quality events, such as the early warning of contaminated product samples, improving efficiency, speeding corrective actions and preventing product loss. Other alerts ensure testing compliance, such as indicating when samples have not been properly handled. Escalation emails trigger samples that exceed an action or alert limit. Device alarms sound when quality anomalies occur.
Early notification of contamination allows the QC lab to take action earlier and prevent further product corruption. For example, taking a fermentor offline before its material is combined with other product in-process enables more productive use of plant resources and capacity. Continuous readout of microbial results prior to completion allows users to get an early view of any developing contamination issues and consult proactively with their manufacturing partners to resolve it.
Electronic access to testing results through a company’s Laboratory Information Management System (LIMS) allows key stakeholders beyond the QC lab to view testing results as they are completed, eliminating unnecessary emails, meetings, phone calls and paper. These stakeholders can then take faster remediation based upon sample results, improving their efficiency and focusing on process improvements.
Automating the Quality Control Laboratory
Service Pack 2 focuses on features to streamline workflow and eliminate waste in the QC lab. These new Growth Direct System capabilities allow pharmaceutical companies to efficiently manage their labor resources and changes in workload. For instance, users can increase laboratory testing efficiency through batch loading of samples while providing flexibility to accommodate random access sample loading.
The paperless QC lab is enabled through seamless LIMS connectivity that automates results recording, data management and reporting, a common source of errors. The system automatically archives results and history, integral to regulatory compliance and critical for traceability and audit-ability.
Custom reporting allows users to tailor reports specific to their needs. Users can easily and efficiently adjust reports to match the laboratory convention and business needs. The time saved allows the quality lab to improve efficiency, reduce errors and focus on value-added activities, critical to any Lean Laboratory program.
Rapid Micro Biosystems CEO, Steve Delity says, "Poor productivity in the Pharmaceutical industry is a significant problem. This is costing organizations millions of dollars a year that, when fixed, drop straight to the bottom line. Our enhancements to the Growth Direct™ System help companies compete in a tough global market by automating and modernizing their quality processes and detecting microbes in half the time of traditional methods. This improves manufacturing cycle-time, increases production capacity and productivity to drive quantifiable results.”
About Rapid Micro Biosystems
Rapid Micro Biosystems, a venture-backed company headquartered in Bedford, Massachusetts, provides innovative products for faster detection of microbial contamination in the manufacture of pharmaceutical, biotechnology, and personal care products. The company's Growth DirectTM System, commercialized in 2008, detects contamination earlier, delivering compelling economic benefits to manufacturers while improving their quality process. The Growth DirectTM System is the first and only automated system that accelerates testing, fits with current regulatory practices, and addresses all key applications. For more information, visit www.rapidmicrobio.com.
Endress+Hauser Offers Online Thermowell Sizing Calculator
Free, online thermowell calculation tool compliant with new ASME PTC 19.3 TW-2010 standards simplifies engineer work
Supreme Court DNA Ruling Could Hurt Biotech IndustryFrom The Denver Post Politics
Critics said the ruling would discourage other companies and financial backers from investing in more genetic sequencing research
Supreme Court Says No to Patenting Human GenesFrom The Scientist
The Court unanimously ruled that isolated sequences of human DNA are not eligible for patent protection, but artificial sequences can be patented
All-new Pharma EXPO Debuts in November 2014
Co-located with PACK-EXPO International, ISPE Pharma EXPO will be held in Chicago
Canadian Health Authority Accepts Use of Roche's Rapid Mycoplasma Detection TestFrom Roche
Roche’s Rapid Mycoplasma Detection Test MycoTOOL Receives Acceptance from Canadian Authorities for Release Testing of Biopharmaceutical Roche Product
Over 200 Cardiovascular Disease Drugs in DevelopmentFrom Drug Store News
According a recent report, 215 drugs are now under development for heart disease and stroke.
Sun Pharma to Pay Pfizer $550 MillionFrom Bloomberg.com
India's biggest drugmaker Sun Pharma experiencing huge decline after settling patent litigation with Pfizer
Catalent Pharma Solutions Expands Manufacturing Facility
Investment of nearly $35 million will create more than 90 manufacturing jobs for innovative medicines
Cancer Drug Still Denied Approval By FDAFrom USA Today
The FDA continues to refuse approval for Aveo Oncology's cancer drug tivozanib citing unclear data
Ten Countries Approve Impotence DrugFrom BusinessWeek.com
The impotence drug Vitatos by Apricus has been approved in 10 European countries
- All news »